Form 13-F position report

GOSSAMER BIO INC COM (DE)

Reported by Opaleye Management Inc

GOSS CUSIP 38341P102 Manager CIK 0001595855

Reported 2,725,000 shares, down 820,000 (23.1%) from the prior quarter.

Reported value 64.4%; share count -23.1% vs. the prior quarter.

Reduced
% of reported 13F value 1.01% This manager · Q3 2025
Shares 2,725,000 Quarter-end amount reported
Reported value $7,166,750 Fair value at quarter end
Consecutive quarters held 10 Through Q3 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 4044000
2023-09-30 3959298
2023-12-31 2721258
2024-03-31 2879329
2024-06-30 3522519
2024-09-30 3705692
2024-12-31 4061654
2025-03-31 4716157
2025-06-30 4360350
2025-09-30 7166750
2025-12-31 8432000
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for GOSSAMER BIO INC COM (DE) held by Opaleye Management Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -2,720,000 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 2,720,000 -5,000 (-0.2%) 1.11% $8,432,000 2026-02-17
Q3 2025 Reduced 2,725,000 -820,000 (-23.1%) 1.01% $7,166,750 2025-11-14
Q2 2025 Reduced 3,545,000 -742,415 (-17.3%) 0.88% $4,360,350 2025-08-14
Q1 2025 Reduced 4,287,415 -202,585 (-4.5%) 1.05% $4,716,157 2025-05-15
Q4 2024 Added 4,490,000 +824,990 (22.5%) 0.71% $4,061,654 2025-02-14
Q3 2024 Reduced 3,665,010 -244,990 (-6.3%) 0.62% $3,705,692 2024-11-14
Q2 2024 Added 3,910,000 +1,469,891 (60.2%) 0.8% $3,522,519 2024-08-14
Q1 2024 Reduced 2,440,109 -542,091 (-18.2%) 0.63% $2,879,329 2024-05-15
Q4 2023 Reduced 2,982,200 -1,772,000 (-37.3%) 0.72% $2,721,258 2024-02-14
Q3 2023 Added 4,754,200 +1,384,200 (41.1%) 1.29% $3,959,298 2023-11-15
Q2 2023 New 3,370,000 +3,370,000 (0.0%) 0.97% $4,044,000 2023-08-14

Who else reported the position

180 managers reported GOSSAMER BIO INC COM (DE) for Q3 2025.

Managers reporting GOSSAMER BIO INC COM (DE) in Q3 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 18,093,034 0 2.61% $47,584,679 13 qtrs
Octagon Capital Advisors LP Reduced 17,050,000 -1,300,000 6.8% $44,841,500 20 qtrs
BlackRock Inc Added 13,846,054 +1,703,458 < 0.01% $36,415,120 5 qtrs
VANGUARD GROUP INC Added 12,009,773 +598,981 < 0.01% $31,585,704 27 qtrs
ARCH Venture Management LLC Unchanged 8,055,916 0 4.3% $21,187,059 9 qtrs
Samsara BioCapital LLC Unchanged 6,130,268 0 2.1% $16,122,605 9 qtrs
Palo Alto Investors LP Reduced 5,464,349 -274,664 2.66% $14,371,238 22 qtrs
Siren L L C Unchanged 5,208,968 0 0.54% $13,699,586 5 qtrs
683 Capital Management LLC Reduced 5,059,200 -1,280,800 0.7% $13,305,696 9 qtrs
ACADIAN ASSET MANAGEMENT LLC Reduced 5,012,969 -2,133,053 0.02% $13,181,000 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2025
Filed
November 14, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,725,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.